Top Markets
Coin of the day
Oxford Cannabinoid Technologies Holdings Plc Oxford Cannabinoid Technologies Holdings Plc

Oxford Cannabinoid Technologies Holdings Plc

OCTP
Rang in aandelen #41534
Oxford Cannabinoid Technologies Holdings Plc operates as a pharmaceutical... Oxford Cannabinoid Technologies Holdings Plc operates as a pharmaceutical company, focused on the research, development, and commercialization of cannabinoid-derived prescription medications. Their principal drug candidate, OCT461201, is a selective CB2 receptor agonist in an oral solid dosage format, currently undergoing pre-clinical assessment. It is being developed to target visceral pain associated with Irritable Bowel Syndrome (IBS), as well as a range of neuropathic pain conditions, notably post-herpetic neuralgia. The company is also progressing with OCT130401, another compound in pre-clinical development, intended for the treatment of trigeminal neuralgia. Incorporated in 2017, Oxford Cannabinoid Technologies Holdings Plc is based in London, United Kingdom.
Aandeelprijs
$0.00156481
Laatst gesynchroniseerd: 2024-06-05
Marktkapitalisatie
$17.03K
Verandering (1 dag)
2.11%
Verandering (1 jaar)
0.00%
Land
GB
Handel Oxford Cannabinoid Technologies Holdings Plc (OCTP)

Categorie

Dividendrendementgeschiedenis voor Oxford Cannabinoid Technologies Holdings Plc (OCTP)
Het dividendrendement (TTM) van Oxford Cannabinoid Technologies Holdings Plc (aandelsymbool: OCTP) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Oxford Cannabinoid Technologies Holdings Plc (OCTP) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten